This study examined the effect of hypocapnia (PaCOz 20 mm Hg) on cerebral metabolism and the electroencephalogram (EEG) findings in 12 dogs during nitroglycerin (NTG)-induced hypotension. Previous studies suggest that NTG is a more potent cerebral vasodilator than sodium nitroprnsside or trimethaphan. It was speculated that combining hypocapnia with NTG-induced hypotension would cause less disturbance of cerebral metabolism and the EEG than the disturbances previously reported when hypocapnia was combined with hypotension induced by sodium nitroprnsside or trimethaphan.
p
ATIENTS are generally hyperventilated during neurological surgery. Hyperventilation is employed because the resultant hypocapnia causes cerebral vasoconstriction which decreases cerebral blood volume, thereby lowering intracranial pressure and reducing brain bulk to improve operative conditions. J5, 25 The cerebral vasoconstriction that results from hypocapnia also causes a significant reduction of cerebral blood flow (CBF). However, so long as mean arterial blood pressure (MABP) is maintained at nearly normal levels there is no evidence that hypocapnia of the degree used clinically adversely affects the brain. Both in animal studies and in man, hypocapnia at normal MABP causes no significant disturbance of cerebral metabolism and no reduction in the power of the electroencephalogram (EEG). 2' 14' 32' 36"38 ' 44 Hyperventilation also may be used at times when MABP is not normal. For example, controlled hypotension is often induced during clipping of intracranial aneurysms subsequent to hyperventilating the patient. A recent study from this laboratory has reported that combining hypocapnia with hypotension causes significant cerebral disturbances. 2 When sodium nitroprusside, a direct-acting vasodilator, was used to lower MABP to 60, 50, and 40 mm Hg, hypocapnia caused a significant deterioration of cerebral metabolism and EEG, as well as continued loss of EEG power at 30 minutes after restoration of normocapnia and normotension. When trimethaphan (a ganglionic blocker) was used to lower MABP to 60, 50, and 40 mm Hg, hypocapnia caused an even greater deterioration of cerebral metabolism and EEG, and loss of EEG power contin-ued 30 minutes after restoration of normocapnia and normotension. Studies by others suggest that the better outcome obtained with sodium nitroprusside compared to results with trimethaphan is due to greater preservation of CBF. The CBF was better maintained with hypotension induced by sodium nitroprusside than by trimethaphan when MABP was lowered to 26 to 28 mm Hg in cats, ~7 and when MABP was lowered to approximately 40 mm Hg in dogs. 35 ' 47 We speculated that the use of nitroglycerin (NTG) rather than sodium nitroprusside or trimethaphan for elective controlled hypotension might minimize the disturbances of cerebral metabolism and EEG caused by combining hypocapnia and hypotension. Our speculation was based on previous reports of the beneficial effect of NTG on CBF during elective controlled hypotension. Hoffman, et al.,2~ reported that CBF did not decrease compared to control values when NTG was used to reduce MABP from 155 mm Hg to 46 mm Hg in hypertensive rats, or when NTG was used to reduce MABP from 130 mm Hg to 42 mm Hg in nonhypertensive rats. In contrast, lowering the MABP by means of sodium nitroprusside or ganglionic blockade (hexamethonium) significantly decreased CBF in hypertensive rats. ~9' 2~ Further, Colley and Sivarajan 9 reported that CBF did not decrease compared to control values when NTG was used to reduce MABP from 82 mm Hg to 45 mm Hg in dogs, whereas CBF decreased by 17% to 28% when sodium nitroprusside was used to reduce MABP from 84 mm Hg to 45 mm Hg.
Considered together, these studies suggest that CBF is better preserved when NTG is used to lower MABP than with the use of sodium nitroprusside or trimethaphan. If so, then the cerebral metabolic and EEG disturbances caused by hypocapnia combined with hypotension may also be less when NTG is used for elective controlled hypotension. Accordingly, the present study was designed to examine cerebral metabolism and EEG's during NTG-induced hypotension in dogs. Hypotension was induced at MABP levels of 60, 50, and 40 mm Hg. These levels were chosen because they encompass the range commonly used for elective controlled hypotension in clinical practice.
Materials and Methods

Animal Preparation
Twelve unmedicated mongrel dogs, each weighing 12.7 to 23.2 kg, were anesthetized with halothane (> 1%) and nitrous oxide (66%) in 02. The trachea was intubated and ventilation was controlled with a Harvard pump and adjusted along with the inspired 02 concentration to maintain initial blood-gas tensions at a PaO2 of over 120 mm Hg and a PaCO2 of 40 _ 1 mm Hg* (values are means + standard errors of the mean). With the animal in the lateral position, a urinary catheter was placed and both femoral veins were cannulated for fluid and drug administration and reinfusion of blood collected from a sagittal sinus cannula (see below). Intravenous infusion of succinylcholine, 50 to 120 mg/hr, maintained muscle relaxation. The fight femoral artery was cannulated for arterial blood sampling for blood-gas analyses and for continuous monitoring of systemic arterial pressure and heart rate. The MABP was determined by electronic integration. Expired CO2 was continuously monitored via a Beckman LB-2 medical gas analyzer.t Temperature was monitored by a nasopharyngeal thermistor probe and maintained at 37.0 ~ + 0.5~ by heat lamps or ice packs. Depletion of vascular volume was minimized by continuous infusion of saline, 4 to 6 ml 9 kg -~ 9 hr -~. The animal was then turned to the prone position and the head was slightly elevated and fixed in a stereotaxic frame. The zero reference for the strain gauge used to measure systemic arterial pressure was set at the level of the top of the dog's head.
Studies of CMR02 and EEG
Six of the 12 dogs were surgically prepared for measurement of CBF and the cerebral metabolic rate of oxygen (CMRO2), and for EEG recording. The method of measurement of CBF has been described in detail previously 34 and is summarized here. The sagittal sinus was exposed via craniectomy and, following systemic intravenous infusion of 8000 U of heparin, the posterior sagittal sinus was incised and a snug-fitting tapered nylon catheter (2 mm in internal diameter) was passed 2 to 4 mm anteriorly. The sinus was packed with strips of Surgicel through another incision just posterior to the catheter, assuring total diversion of sagittal sinus flow through the catheter. The distal tip of the catheter was placed at the level of the base of the skull, and flow from the catheter was collected in a reservoir and returned by a roller pump to the femoral vein. The reservoir and pump were initially primed with saline, and the fluid level in the reservoir was maintained at 100 + 2 ml/kg. Sagittal sinus blood samples for measurement of oxygen tension were drawn into syringes through a side-arm at the distal tip of the sagittal sinus outflow catheter by gentle aspiration. At each experimental condition (see Table 1 ), CBF was determined from three to five timed collections of outflow from the sagittal sinus catheter. Along with each determination of CBF, the CMRO2 was determined as the product of CBF and the difference between arterial and sagittal sinus 02 content (CaO2 -CvO2). The O2 content in both arterial and sagittal sinus blood was determined from measurements of 02 tension, hemoglobin concentration using an IL 182 CO-Oximeter,~ and 02 * Pump manufactured by Harvard Apparatus Co., Millis, Massachusetts; BMS MK2 electrodes for blood-gas measurement made by Radiometer A/S, Copenhagen, Denmark. t LB-2 medical gas analyzer manufactured by Beckman Instruments, Inc., Fullerton, California.
CO-Oximeter manufactured by Instrumentation Laboratory, Inc., Lexington, Massachusetts. 40 normal * MABP = mean arterial blood pressure. saturation 6'3~ calculated using 1.36 ml/gm as the 02-carrying capacity of hemoglobin, 45 as reported previously. 2 Conversion of CBF values from ml/min to ml 9 min -~ 9 100 gm -t was based on the portion of brain that contributed to sagittal sinus flow, namely 48%, as reported previously) Three to five CBF values and three to five CMRO2 values were averaged to provide representative mean CBF and CMRO2 values for each experimental condition.
Also, at each experimental condition (see Table 1 ) concentrations of lactate, pyruvate, and glucose in arterial blood samples were determined by standard techniques, and the lactate/pyruvate (L/P) ratio was calculated. The EEG was recorded using bilateral frontoparietal electrodes and a Beckman polygraphw with a bandpass of 0.3 to 75 Hz. Electrodes were adjusted to maintain impedances between electrode pairs at less than 3 kohm. Computer analysis of the EEG was performed using a compressed spectral array program which averaged the EEG power spectra of four epochs (one epoch = 4 seconds) every 30 to 40 seconds. 7'29 For each experimental condition, the EEG power spectra for that time period were averaged to provide mean power in the standard frequency bins: delta (& 1 to 4 Hz), theta (0, 4 to 8 Hz), alpha (a, 8 to 14 Hz), beta 1 (/31, 14 to 20 Hz), and beta 2 (~2, 20 to 32 Hz).
After completion of the surgical preparation, the expired concentration of halothane was decreased to 0.2% (end-tidal concentration determined by gas chromatography). After stable measurements of cerebral and systemic variables were obtained (at least 25 minutes later), CBF, CMRO2, EEG, and systemic variables were determined in sequence at each of the experimental conditions shown in Table 1 . Each condition was maintained for 30 minutes, with 25 minutes allowed to achieve and hold the desired condition and 5 minutes used to determine all cerebral and systemic variables (except the EEG which was recorded during the final 10 minutes of each condition). Hyperventilation was used to decrease PaCO2, and continuous intravenous infusion of NTG]I was used to decrease MABP. In all w Accutrace 100A EEG polygraph manufactured by Beckman Instruments, Fullerton, California.
II Nitro-Bid (nitroglycerin) generously supplied by Marion Laboratories, Inc., Kansas City, Missouri.
A. A. Artru, K. Wright and P. S. Colley six dogs, after values were determined at Condition 6, a brain biopsy specimen was obtained for determination of brain tissue metabolites.
Studies of Brain Tissue Metabolites
The other six dogs were surgically prepared for measurement of brain tissue concentrations of adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), phosphocreatine (PCr), lactate, pyruvate, and glucose. A craniectomy was performed and the dura overlying the cerebral hemispheres was excised. At each experimental condition, brain tissue samples were obtained using a suction technique that deposits a 200-to 400-rag tissue sample into liquid nitrogen within 1 second. 26 At least 2 cm of brain was left between biopsy sites to prevent tissue reaction at early biopsy sites from disturbing metabolite values at later biopsy sitesfl 6 Each tissue sample was stored at -76~ for no longer than 24 After completion of the surgical preparation, the expired concentration of halothane was decreased to 0.2%. Stable measurements of systemic variables were obtained at least 25 minutes later, then brain tissue was sampled and systemic variables were determined at the same experimental conditions as for the studies of CMRO2 and EEG, allowing 30 minutes at each condition. Hyperventilation was used to decrease PaCO2, and continuous intravenous infusion of NTG was used to decrease MABP.
Cerebral and systemic variables were compared between conditions using analysis of variance for repeated measures. 8 Values at Conditions 2 to 6 were compared to values at Condition 1, and values at Conditions 3 to 5 were compared to values at Condition 2. Where the calculated F value exceeded the critical value for 0.05 probability, a paired t-test using the Bonferroni procedure was employed to make comparisons within the groups. 49 A p value of less than 0.05 was considered significant.
Results
During normotension, reducing the PaCO2 caused a significant decrease of CBF, p02 in the sagittal sinus, and brain tissue glucose (Tables 2 and 3 ). The power of the/32 spectrum of the EEG (Fig. 1 ), brain tissue lactate, and brain tissue pyruvate were all increased, although the brain tissue L/P ratio was not significantly altered. Systemic variables were also affected by hypo- capnia. The PaO2 and arterial blood pH increased, while arterial blood bicarbonate levels decreased. Combining hypocapnia with NTG-induced hypotension caused additional changes (Tables 2 and 3) . At MABP's of 60 mm Hg or less, the power of the a and t2 spectra of the EEG decreased compared to values during hypocapnia and normal MABP. At an MABP of 40 mm Hg, CBF, brain tissue PCr, and the energy charge fell, while CaO2 -CvO/and the brain tissue L/P ratio increased. Systemically, hypotension plus hypocapnia was accompanied by a decrease of arterial blood bicarbonate and pyruvate levels and an increase in the arterial blood L/P ratio at an MABP of 50 mm Hg or less.
With restoration of normal MABP and PaCO2, cerebral metabolites returned to initial values. However, CBF and the power of the a and t2 spectra of the EEG were decreased compared to initial values at normal MABP and PaCO2 levels. Brain-biopsy samples taken at the end of the studies from animals surgically prepared for determination of CMRO2 and EEG were not significantly different from those taken at the end of the study from animals surgically prepared for serial brain-biopsy sampling (Table 4) .
Discussion
Experimental Methods
In the present study, we examined all 12 dogs at normal PaCO2 and MABP and at hypocapnia alone as baseline controls for the effects of hypocapnia combined with hypotension. It is conceivable that the effects of hypocapnia combined with hypotension could be due to hypotension alone. Thus, the need to also examine all dogs at normal PaCO2 and MABP's of 60, 50, and 40 mm Hg as controls for hypocapnia combined with hypotension was considered. This idea was abandoned because the additional comparisons would have prolonged the study beyond the useful life of the experimental preparation. It is unlikely, however, that cerebral metabolism and EEG findings would be altered by normocapnia plus NTG-induced hypotension. Previous studies reported no change in CBF when NTG was used to reduce MABP either to 42 mm Hg in rats 21 or to 45 mm Hg in dogs. 9 Assuming that CBF is preserved at normal levels during normoeapnia plus NTG-induced hypotension, cerebral metabolism and EEG should remain unchanged. To confirm this, we did examine the effects of NTG-induced hypotension on an additional group of eight normocapnic dogs. We observed no significant change in the EEG or CMRO2 30 to 40 minutes after the MABP was lowered to 45 to 55 mm Hg with NTG administration. Also, we did not randomize the sequence of experimental conditions at which the dogs were examined. Instead, dogs were examined first under baseline control conditions, then at experimental conditions with the most severe stress being examined last. We chose this sequence because of the possibility that 30 minutes at a PaCO2 of 20 mm Hg and an MABP of 40 mm Hg might cause ischemic brain damage making examination at any additional conditions meaningless.
Significance of Current Findings
The present results suggest that minimal disturbances of cerebral metabolism and function occur during hypocapnia plus NTG-induced hypotension to MABP's of 60 mm Hg or 50 mm Hg. At these levels of hypotension, cerebral metabolite levels were unchanged and the only significant alteration of the EEG was a decrease in the power of the a and t2 spectra. The importance of these declines in EEG power is unclear. Previous studies of the EEG during hypoxia or ischemia have reported initial increases of a and/or /3 activity followed by decrease of a activity with or without decrease of 13 activity. 10, 13, 23, 24, 37, 42 In these previous studies, the initial increase of a and/or fl activity was transient and may have been missed in the present study since the EEG was recorded only during the final 10 minutes of each 30-minute experimental period. However, it seems unlikely that the decrease of ~ and/32 activity observed here was the result of hypoxic/ischemic cerebral damage since cerebral metabolites were not disturbed.
The present results demonstrate a significant disturbance of cerebral metabolism during hypocapnia plus NTG-induced hypotension to an MABP of 40 mm Hg. The pattern of these cerebral metabolic changes indicates that they resulted directly from the combination of hypocapnia and NTG-induced hypotension, and did not occur secondary to the increase in systemic arterial lactate. Although an increase in the L/P ratio in arterial blood over 30 minutes can increase the L/P ratio in brain tissue, other metabolic disturbances (such as de- Table 1 ). Each EEG trace represents 2 seconds of EEG activity recorded at 30 mm/sec. The calibration mark denotes 50 ~zV. The CSA data are displayed at 30-second intervals. MAP = mean arterial pressure.
crease of brain tissue PCr and the energy charge) will not occur unless the brain tissue lactate concentration reaches 20 to 30 umol/gm. 41 In the present study, brain tissue lactate concentrations rose only to 5.13 ___ 0.41 umol/gm. Thus, the increase of the L/P ratio of brain tissue seen here indicates that, at an MABP of 40 mm Hg, the delivery of oxygen to the brain became inadequate when CBF fell, resulting in an increase of anaerobic cerebral metabolism? 4 The decrease of PCr and the energy charge of the cerebral tissue suggests a deficit of cerebral energy production relative to energy utilization. 4'5 These results are consistent with the concept that a reduction of CBF by 50% is tolerated but that any further fall in flow causes failure of cerebral energy production. 44 That CMRO2 was not significantly changed with the combination of hypocapnia and NTG-induced hypotension to an MABP of 40 mm Hg is consistent with previous reports that CMRO2 de- cerebral metabolic rate of oxygen; CBF = cerebral blood flow; MABP = mean arterial blood pressure; PCr = phosphocreatine; ATP = adenosine triphosphate; ADP = adenosine diphosphate; AMP = adenosine monophosphate; ~Ad = the sum of the adenine nucleotides; L/P ratio = lactate/pyruvate ratio.
creases only when MABP is reduced to values lower than those at which decreases in the cerebral energy state are observed. 23 ' 35 The possibility that lowering MABP to 60 mm Hg for 30 minutes then to 50 mm Hg for 30 minutes more affected the results observed at 40 mm Hg cannot be ruled out. However, this seems unlikely because the effects of 60 minutes at MABP's of 50 to 60 mm Hg were minimal. In addition, it is possible that the cerebral metabolic and EEG changes caused by NTG-induced hypotension to an MABP of 40 mm Hg combined with hypocapnia would also occur during NTG-induced hypotension to an MABP of 40 mm Hg at normocapnia. This also seems unlikely, considering that CBF did not decrease when NTG was used to lower MABP to 42 mm Hg in normocapnic rats zl and did not decrease below normal values when NTG was used to lower MABP to 45 mm Hg in normocapnic dogs. 9 Cerebral metabolite and EEG findings should not deteriorate so long as CBF is preserved. 44 Comparing the present studies with our previous results with sodium nitroprusside and trimethaphan demonstrates that the cerebral metabolism and EEG disturbances seen here with the combination of hypocapnia and NTG-induced hypotension were similar to those previously reported during hypocapnia plus hypotension induced by sodium nitroprusside and less than those previously reported during hypocapnia plus trimethaphan-induced hypotension. With hypocapnia plus sodium nitroprusside-induced hypotension the power of the a and/32 spectra of the EEG decreased at an MABP of 60 mm Hg or less, and at an MABP of 40 mm Hg the CBF, energy charge, and brain tissue PCr level fell while the L/P ratio in brain tissue increased. 2 Identical cerebral metabolism and EEG disturbances were observed in the present studies with hypocapnia combined with NTG-induced hypotension. In contrast, with hypocapnia plus trimethaphan-induced hypotension, a and ~2 activity decreased at an MABP of 60 mm Hg or less;/~1 activity, the brain tissue PCr level, and the energy charge decreased at an MABP of 50 mm Hg or less; and CBF and the brain tissue glucose level fell and the L/P ratio in brain tissue increased at an MABP of 40 mm Hg. 2 Thus, the disturbances caused by hypocapnia combined with trimethaphan-induced hypotension were more severe than those observed with NTG. Thirty minutes after recovery from hypocapnia plus NTG-induced hypotension, cerebral values were similar to those at 30 minutes after recovery from hypocapnia combined with either sodium nitroprusside-or trimethaphan-induced hypotension, z However, EEG activity recovered more completely 30 minutes after hypocapnia plus NTG-induced hypotension than at 30 minutes after hypocapnia plus trimethaphaninduced hypotension. 2 That CBF values at the end of the present study were decreased compared to pretreatment values is consistent with the time-related decrease of CBF previously reported in dogs with craniotomy and cannulation of the sagittal sinus or torcular. 33'4~ Those studies reported that CBF decreases of 20% to 25% occurred over 2 to 2 89 hours, and that the decrease was independent of the method used to determine CBF. A second factor contributing to the time-related decrease of CBF observed in the present study may be adaptation to the cerebral vasodilating effects of halothane. Albrecht, et al., ~ reported that, in goats anesthetized with halothane (1% inspired in O2), CBF was doubled during the first 30 minutes then decreased and approached pre-halothane values over the next 2 hours.
Agreement between certain results of the present study and those of previous studies supports the suitability of this model for determining cerebral metabolism and CBF: 1) At a normal MABP, hypocapnia caused an increase of brain tissue lactate and pyruvate and a decrease of brain tissue glucose levels with no change in L/P ratio, CMRO:, or Pfr. 11 '12'14'28'36'38'43'48 2) At a normal MABP, hypocapnia caused a 40% reduction of CBF. 15"25 3) The CBF decreased as MABP was lowered below 50 mm Hg. 16,22,27,39,50 4) Brain-biopsy values obtained at the end of this study showed that 30 minutes of cerebral perfusion at normal MABP and at a PaCOz of 40 mm Hg reversed the cerebral metabolic disturbances caused by hypocapnia and hypotension. ~8'46 Of particular interest regarding end-study brain-biopsy values was the finding that values from dogs in which the CMRO2, CBF, and EEG were recorded were similar to end-study brain-biopsy values from dogs in which this surgical intervention was not performed. These results are consistent with a previous finding that taking serial brain biopsies causes no change in metabolite levels if sufficient distance is left between sample sites. 26 Furthermore, these results suggest that 3 hours of sagittal sinus cannulation does not disturb cerebral metabolism. Based on the above results, A. A. Artru, K. Wright and P. S. Colley cerebral metabolism and circulation appear to have responded appropriately to physiological changes, and the present preparation was suitable to measure those responses.
Conclusions
Hypocapnia combined with NTG-induced hypotension caused cerebral metabolic disturbances and alterations of the EEG that were similar to those previously reported to occur during hypocapnia combined with sodium nitroprusside-induced hypotension, and less than those found during hypocapnia combined with trimethaphan-induced hypotension. Cerebral values observed 30 minutes after recovery from hypocapnia plus NTG-induced hypotension (namely, normal cerebral metabolite levels but a decrease in high-frequency EEG activity) were similar to those previously reported 30 minutes after recovery from hypocapnia plus sodium nitroprusside-or trimethaphan-induced hypotension. The beneficial effects of NTG on cerebral metabolism and EEG seen here are not so great as the beneficial effects of NTG on CBF that were documented in studies evaluating the use of NTG, sodium nitroprusside, and trimethaphan for controlled hypotension.
